Patents by Inventor So Min KANG

So Min KANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Usnic acid derivative having TSLP secretion inhibitory ability and use thereof
    Patent number: 12152011
    Abstract: The present invention relates to a novel Usnic acid derivative exhibiting an inhibitory effect on TSLP secretion or pharmaceutically acceptable salts thereof, and a use thereof.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: November 26, 2024
    Assignee: SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Chan Yeong Heo, So Min Kang, Da Som Jeon
  • USNIC ACID DERIVATIVE HAVING TSLP SECRETION INHIBITORY ABILITY AND USE THEREOF
    Publication number: 20210395214
    Abstract: The present invention relates to a novel Usnic acid derivative exhibiting an inhibitory effect on TSLP secretion or pharmaceutically acceptable salts thereof, and a use thereof.
    Type: Application
    Filed: October 10, 2019
    Publication date: December 23, 2021
    Applicant: SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Chan Yeong HEO, So Min KANG, Da som JEON
  • TRPV1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same
    Patent number: 9511011
    Abstract: TRPV1 inhibitory peptides and a composition for skin-aging prevention and wrinkle improvement comprising the same as an active ingredient are described. The TRPV1 inhibitory peptide of the present subject matter inhibits the expressions of MMP and proinflammatory cytokines induced by UV exposure and reduces skinfold thickness and intracellular Ca2+ influx, so that it can be effectively used as an active ingredient of the composition for skin-aging prevention, wrinkle improvement, skin-whitening, or alleviating inflammation, irritation, or pain.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: December 6, 2016
    Assignee: SNU R&DB FOUNDATION
    Inventors: Jin Ho Chung, So Min Kang, Young Mee Lee, Yeon Kyung Kim
  • NOVEL TRPV1 INHIBITORY PEPTIDES AND COMPOSITION FOR SKIN-AGING PROTECTION OR WRINKLE IMPROVEMENT COMPRISING THE SAME
    Publication number: 20150257998
    Abstract: The present invention relates to a novel TRPV1 inhibitory peptide and a composition for skin-aging prevention and wrinkle improvement comprising the same as an active ingredient. The TRPV1 inhibitory peptide of the present invention inhibits the expressions of MMP and proinflammatory cytokines induced by UV exposure and reduces skinfold thickness and intracellular Ca2+ so that it can be effectively used as an active ingredient of the composition for skin-aging prevention, wrinkle improvement, skin-whitening, or alleviating inflammation, irritation, or pain.
    Type: Application
    Filed: May 29, 2015
    Publication date: September 17, 2015
    Applicant: SNU R&DB FOUNDATION
    Inventors: Jin Ho CHUNG, So Min KANG, Young Mee LEE, Yeon Kyung KIM
  • TRPV1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same
    Patent number: 9056889
    Abstract: TRPV1 inhibitory peptide and a composition thereof for skin-aging prevention, wrinkle improvement, skin-whitening, or alleviating inflammation, irritation or pain is described, where the TRPV1 inhibitory peptide inhibits the expressions of MMP and proinflammatory cytokines induced by UV exposure and reduces skinfold thickness and intracellular Ca2+influx.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: June 16, 2015
    Assignee: SNU R&DB FOUNDATION
    Inventors: Jin Ho Chung, So Min Kang, Young Mee Lee, Se Rah Lee, Yeon Kyung Kim
  • NOVEL TRPV1 INHIBITORY PEPTIDES AND COMPOSITION FOR SKIN-AGING PROTECTION OR WRINKLE IMPROVEMENT COMPRISING THE SAME
    Publication number: 20130243711
    Abstract: The present invention relates to a novel TRPV1 inhibitory peptide and a composition for skin-aging prevention and wrinkle improvement comprising the same as an active ingredient. The TRPV1 inhibitory peptide of the present invention inhibits the expressions of MMP and proinflammatory cytokines induced by UV exposure and reduces skinfold thickness and intracellular Ca2+ so that it can be effectively used as an active ingredient of the composition for skin-aging prevention, wrinkle improvement, skin-whitening, or alleviating inflammation, irritation, or pain.
    Type: Application
    Filed: April 2, 2013
    Publication date: September 19, 2013
    Applicant: SNU R&DB FOUNDATION
    Inventors: Jin Ho CHUNG, So Min KANG, Young Mee LEE, Se Rah LEE, Yeon Kyung KIM